High-risk HPV testing on a Pap test - For a Healthy Belgium

Key figures
Data
Graphics
Comments

PROVIDERS & PRESCRIBERS
Main healthcare providers: Pathological anatomy	50.49%
Main prescribers: Pathological anatomy	92.81%
RATE OF USE
Average number of interventions (per year)	23,441
Standardised rate of use (per 100,000 insured persons)	783.14
≥ 2 occurences per patient 2021	0.11%
Percentage of outpatient care	99.76%
POPULATION
Median age	40 years
Max/min ratio of the median age (by district)	1.19
Percentage of women	100.00%
Ratio Preferential scheme/General scheme	0.90
TRENDS
Trend 2012-2022	2.42%
Trend 2012-2019	3.11%
Trend 2019-2022	0.83%
GEOGRAPHICAL VARIATIONS
Coefficient of variation 2012-2014	38.95
Coefficient of variation 2020-2022	24.44
Max/min ratio of number of interventions (per 100,000 insured persons, by region)	1.17
Max/min ratio of number of interventions (per 100,000 insured persons, by district)	3.67
DIRECT EXPENDITURE
Average annual expenditure	1,320,739 €
Average annual expenditure per insured person	0.44 €
Max/min ratio of expenditure per insured person (by region)	1.18
Max/min ratio of expenditure per insured person(by district)	3.73
Average cost of interventions	56.34 €

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.

+ - NIHDI nomenclature codes selected for analysis Click to collapse

CODES	LABEL	CREATION	DELETION
588932 588943	Recherche d’HPV à haut risque au moyen d’une méthode de diagnostic moléculaire, suivant la prestation 589853-589864 ou 588873-588884, sur le(s) même(s) prélèvement(s) cervico-vaginal(aux)	01-07-2009